UBS Group’s Dermata Therapeutics DRMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2K | Buy |
90,955
+20,665
| +29% | +$12.1K | ﹤0.01% | 6435 |
|
|
2025
Q1 | $75.9K | Buy |
70,290
+56,416
| +407% | +$60.9K | ﹤0.01% | 5983 |
|
|
2024
Q4 | $18.7K | Buy |
13,874
+12,377
| +827% | +$16.7K | ﹤0.01% | 6689 |
|
|
2024
Q3 | $2.46K | Sell |
1,497
-208
| -12% | -$341 | ﹤0.01% | 7211 |
|
|
2024
Q2 | $4.08K | Buy |
+1,705
| New | +$4.08K | ﹤0.01% | 6971 |
|
|
2023
Q4 | – | Sell |
-131
| Closed | -$139 | – | 8165 |
|
|
2023
Q3 | $139 | Sell |
131
-6,879
| -98% | -$7.3K | ﹤0.01% | 7656 |
|
|
2023
Q2 | $11.6K | Buy |
7,010
+3,565
| +103% | +$5.88K | ﹤0.01% | 6025 |
|
|
2023
Q1 | $4.44K | Sell |
3,445
-33,863
| -91% | -$43.7K | ﹤0.01% | 7090 |
|
|
2022
Q4 | $15.3K | Buy |
37,308
+22,510
| +152% | +$9.23K | ﹤0.01% | 6812 |
|
|
2022
Q3 | $8K | Buy |
14,798
+3,591
| +32% | +$1.94K | ﹤0.01% | 7595 |
|
|
2022
Q2 | $7K | Buy |
11,207
+6,884
| +159% | +$4.3K | ﹤0.01% | 7429 |
|
|
2022
Q1 | $5K | Buy |
+4,323
| New | +$5K | ﹤0.01% | 8051 |
|
|
2021
Q4 | – | Sell |
-189
| Closed | -$1K | – | 9157 |
|
|
2021
Q3 | $1K | Buy |
+189
| New | +$1K | ﹤0.01% | 8011 |
|